News

Protection against RSV derived from preF IgG antibodies waned 6 months after infection in an analysis of patients with confirmed disease and household contacts.
The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...
Frailty was a significant predictor of severe outcomes and hospitalization characteristics in older adults hospitalized with RSV infection.
Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...
A letter to the US public on the AMA website, signed by 75+ medical societies, stresses the vital importance of influenza, ...
GSK has become the first pharma company to get regulatory approval for a vaccine against respiratory syncytial virus (RSV), setting up what looks set to be a highly lucrative – and likely ...